Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice
In Vivo · 2023
DOI: 10.21873/invivo.13173 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2023. Verfasst von Diamantis I Tsilimigras und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Surgery, First Propedeutic Department of Surgery, Hippokration Hospital, National and Kapodistrian University of Athens, Athens,…. Hauptthemen laut MEDLINE: Atherosclerosis, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Plaque, Atherosclerotic. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Vascular Surgery, First Propedeutic Department of Surgery, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece; diamantis.tsilimigras@gmail.com.
- N.S. Christeas Laboratory for Experimental Surgery and Surgical Research National and Kapodistrian University of Athens, Athens, Greece.
- Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
- First Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
- Division of Vascular Surgery, First Propedeutic Department of Surgery, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Zitieren
APA
Tsilimigras, D. I., Thanopoulou, K., Salagianni, M., Siasos, G., Oikonomou, E., Perrea, D. D., Nirakis, N., Filis, K., Tsioufis, K., Tousoulis, D., & Sigala, F. (2023). Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice. In Vivo. https://doi.org/10.21873/invivo.13173
Vancouver
Tsilimigras DI, Thanopoulou K, Salagianni M, Siasos G, Oikonomou E, Perrea DD, et al. Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice. In Vivo. 2023. doi:10.21873/invivo.13173
BibTeX
@article{Tsilimigras2023,
author = {Tsilimigras, Diamantis I and Thanopoulou, Kalliopi and Salagianni, Maria and Siasos, Gerasimos and Oikonomou, Evangelos and Perrea, Despina D and Nirakis, Nikolaos and Filis, Konstantinos and Tsioufis, Konstantinos and Tousoulis, Dimitrios and Sigala, Fragiska},
title = {Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice},
journal = {In Vivo},
year = {2023},
doi = {10.21873/invivo.13173}
}
EUVIMED